SBI Securities’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

SBI Securities’s Portfolio LABD Stock Details LABD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.84K	Buy	1,146 +108	+10%	+$1.45K	﹤0.01%	1902
2026 Q1	$16.9K	Buy	1,038 +192	+23%	+$3.63K	﹤0.01%	1529
2025 Q4	$17.8K	Buy	846 +223	+36%	+$6.05K	﹤0.01%	1487
2025 Q3	$25.2K	Buy	623 +433	+228%	+$25.1K	﹤0.01%	1358
2025 Q2	$14.2K	Buy	190 +109	+135%	+$9.64K	﹤0.01%	1543
2025 Q1	$7.65K	Buy	81 +22	+37%	+$1.61K	﹤0.01%	1711
2024 Q4	$4.25K	Buy	+59	New	+$3.61K	﹤0.01%	1982

Other funds holding LABD

CCM

Capstone Capital Management Hong Kong $224M AUM

PayPay Securities Tokyo, Japan $4.1M AUM 0.16% 1-Year Est. Return

SBI Securities's LABD Position: Q2 2026 in Review

SBI Securities increased its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 10% in Q2 2026, buying an estimated $1.45K and bringing the position to 1,146 shares worth $8.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

SBI Securities first reported a position in LABD in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.2K in Q3 2025. 3 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

SBI Securities held 1,146 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $8.84K as of Q2 2026.
SBI Securities bought 108 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2026, an estimated $1.45K.
Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1902 holding.
SBI Securities first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $25.2K in Q3 2025.
3 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.